EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rola miRNA w patogenezie, diagnostyce i spersonalizowanej terapii glejaka wielopostaciowego

Anna Bielecka-Wajdman

Postępy Biochemii · 30.06.2026 · 72 (2) · 125-142

DOI: 10.18388/cjm9bt80 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Postępy Biochemii, online erschienen am 30.06.2026. Verfasst von Anna Bielecka-Wajdman. Beteiligte Einrichtung: Zakład Farmakologii, Katedra Farmakologii, Śląski Uniwersytet Medyczny w Katowicach. Hauptthemen laut MEDLINE: MicroRNAs, Glioblastoma, Brain Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is a malignant, hypercellular, and invasive brain tumor characterized by high mortality and recurrence. Their strong heterogeneity, mitotic activity, microvascular proliferation, and foci of necrosis induce therapeutic resistance, resulting in a 5-year survival rate of only 5% in patients diagnosed with glioblastoma. Therefore, it is necessary to identify new targets to improve prognosis, better predict prognosis, and monitor treatment outcomes. It has been suggested that miRNAs—small, single-stranded, non-coding RNAs consisting of 20-22 nucleotides—may be potential candidates for clinical biomarkers in glioblastoma patients. They participate in the post-translational regulation of gene expression through RNA interference. It is believed that, due to their ability to control the biological processes underlying GBM development, miRNAs may aid in the design of drugs for personalized glioma therapy. This article presents the latest insights into the role of miRNAs in the pathogenesis and diagnosis of GBM and as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGlioblastomaBrain NeoplasmsHumansPrecision MedicineBiomarkers, TumorPrognosisGene Expression Regulation, Neoplastic

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Zakład Farmakologii, Katedra Farmakologii, Śląski Uniwersytet Medyczny w Katowicach.

Zitieren

APA

Bielecka-Wajdman, A. (2026). Rola miRNA w patogenezie, diagnostyce i spersonalizowanej terapii glejaka wielopostaciowego. Postępy Biochemii, 72(2), 125-142. https://doi.org/10.18388/cjm9bt80

Vancouver

Bielecka-Wajdman A. Rola miRNA w patogenezie, diagnostyce i spersonalizowanej terapii glejaka wielopostaciowego. Postępy Biochemii. 2026;72(2):125-142. doi:10.18388/cjm9bt80

BibTeX
@article{BieleckaWajdman2026,
  author = {Bielecka-Wajdman, Anna},
  title = {Rola miRNA w patogenezie, diagnostyce i spersonalizowanej terapii glejaka wielopostaciowego},
  journal = {Postępy Biochemii},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {125--142},
  doi = {10.18388/cjm9bt80}
}
Kostenlos starten →